Skip to content
6-K

Foreign Interim / Material

YD Bio Limited YDES YDESW

0001213900-25-093988

← back to feed
Filed
Sep 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 1K sh
Shares Diluted Q2 2025 · Jun 30, 2024 1K sh
Stockholders Equity Q2 2025 · Jun 30, 2025 −$67.68K
Stockholders Equity Q2 2025 · Dec 31, 2024 −$66.44K
Stockholders Equity Q2 2025 · Jun 30, 2024 $0
Total Liabilities Q2 2025 · Jun 30, 2025 $67.68K
Total Liabilities Q2 2025 · Dec 31, 2024 $66.44K
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.24
Eps Basic Q2 2025 · Jun 30, 2025 −$1.24
Sga Expense Q2 2025 · Jun 30, 2025 $1.24K
Net Income Q2 2025 · Jun 30, 2025 −$1.24K